Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc (JAZZ), sold 155,000 shares at $179.79 ($27.6M) on 2025-11-26, disclosed to the SEC on 2025-12-01.
Seasonal sale ($27.6M) by Director — this insider has traded JAZZ in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $177.27 | 38,126 | $6.8M | 24.5% |
| 2 | $177.27 | 38,126 | $6.8M | 24.5% |
| 3 | $178.06 | 30,487 | $5.4M | 19.7% |
| 4 | $178.06 | 30,487 | $5.4M | 19.7% |
| 5 | $179.23 | 8,380 | $1.5M | 5.4% |
| 6 | $179.23 | 8,380 |
| $1.5M |
| 5.4% |
| 7 | $179.79 | 507 | $91K | 0.3% |
| 8 | $179.79 | 507 | $91K | 0.3% |
| Total | $177.81 avg | 155,000 | $27.6M | 100% |
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-06-03 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |